Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 2354Neoplasms 1704Prostatic Neoplasms 1192Lung Neoplasms 922Colorectal Neoplasms 884Carcinoma, Non-Small-Cell Lung 866Leukemia, Myeloid, Acute 593Pancreatic Neoplasms 574Multiple Myeloma 551Carcinoma, Hepatocellular 516Brain Neoplasms 515Neoplasm Metastasis 461Head and Neck Neoplasms 457Melanoma 414Ovarian Neoplasms 412Glioblastoma 402Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Stomach Neoplasms 376Uterine Cervical Neoplasms 362Squamous Cell Carcinoma of Head and Neck 362Rectal Neoplasms 342Recurrence 335Sarcoma 324Hematologic Neoplasms 324Colonic Neoplasms 321Lymphoma 320Triple Negative Breast Neoplasms 289Carcinoma, Renal Cell 283Urinary Bladder Neoplasms 281Glioma 280

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Solid Tumor Malignancies × 1 year × Clear all
NCT06927297 2026-03-17

Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors

West China Hospital

Phase 1 Recruiting
12 enrolled
Other solid neoplasm

Advanced Solid Tumor Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡